PATENT CLAIM ANALYSIS

Application Number: 16382276
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "001100"]

Abstract:
The present invention is directed to novel lyophilized pharmaceutical preparations comprising a cytotoxic dipeptides such as melphalan flufenamide and one or more excipient(s) selected from the group comprising a polysorbate; a polyethylene glycol; β-cyclodextrin; ocyclodextrin; hydroxypropyl-β-cyclodextrin; sulfobutylether-β-cyclodextrin; lactose; benzyl alcohol; disodium succinate; propylene glycol; Cremophor EL; Dimethyl sulfoxide; D-mannitol; Trehalose; Sucrose and an amino acid. This preparation may be further formulated and is useful in cancer therapy.

Claim (Index 46):
The method of  claim 41 , wherein the lyophilized pharmaceutical preparation contains trace amounts of an organic solvent.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 100.0
- Lexical Diversity: 1.32308
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15225323', '14438473', '15149975', '12374489', '15038235']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7498901612515018
- 35 USC 102 Novelty (BERT): 0.6200570568263116
- Combined Prediction Score: 0.7369068508089828
- Mean Citation Score: 336.39282800000007
- Max Citation Score: 603.6755
- Similarity Product: 475.05123964455726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test